Clinical Trial Details
EORTC-06011
Back to Clinical Trials Database
Intravenous low-dose decitabine versus supportive care in elderly patients with primary Myelodysplastic Syndrome (MDS) (>10% blasts or high-risk cytogenetics), secondary MDS or Chronic Myelomonocytic Leukemia (CMML) who are not eligible for intensive therapy: an EORTC-German MDS Study Group randomized phase III study.
| Trial Status | All trial activities ended |
|---|---|
| Dates |
Date of activation: 23-May-2002 Date Step1 close: 01-Jun-2007 |
| Data management at EORTC | Yes |
| Design |
Phase 3 Randomized open label |
| Targeted Sample size | EORTC Groups: 220 |
| Treatment | |
| Study Staff | |
| Type of cancer | |
| Participating groups | |
| Protocol summary | http://clinicaltrials.gov/study/NCT00043134 |
| NCT number | NCT00043134 |
| EudraCT | 2005-002830-36 |
